Role of EBV in microRNA dysregulation in Burkitt lymphoma. 2009

Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
Department of Human Pathology and Oncology, University of Siena, Via delle Scotte, 6, 53100 Siena, Italy.

Since its discovery as the first human tumor virus, Epstein-Barr virus (EBV) has been implicated in the development of a wide range of B-cell lymphoproliferative disorders, the first being Burkitt lymphoma. However, the exact mechanism by which EBV promotes oncogenesis is still matter of discussion. A role in EBV-mediated transformation has been proposed for a novel described class of small non-coding RNAs, the microRNAs (miRNAs). EBV encodes viral miRNAs, through which it may interfere with the physiological regulation exterted by cellular miRNAs. In addition, EBV-coded proteins may also disturb the well-orchestrated mechanisms of regulation of cellular function. In this review, we will focus on the role of EBV in malignant transformation of Burkitt lymphoma, with a particular insight in the interplay between the virus and cellular miRNAs.

UI MeSH Term Description Entries
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D020031 Epstein-Barr Virus Infections Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY). EBV Infections,Epstein-Barr Virus Infection,Herpesvirus 4 Infections, Human,Human Herpes Virus 4 Infections,Human Herpesvirus 4 Infections,Infections, EBV,Infections, Epstein-Barr Virus,EBV Infection,Epstein Barr Virus Infection,Epstein Barr Virus Infections,Infection, EBV,Infection, Epstein-Barr Virus,Virus Infection, Epstein-Barr,Virus Infections, Epstein-Barr
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
October 2002, Nature medicine,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
January 1994, Antibiotics and chemotherapy,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
May 2020, Blood,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
April 2017, Molecular medicine reports,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
July 2013, Cancer science,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
January 2016, Leukemia & lymphoma,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
November 1981, Acta pathologica et microbiologica Scandinavica. Section A, Pathology,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
October 1983, Journal of submicroscopic cytology,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
October 2016, Medical science monitor : international medical journal of experimental and clinical research,
Giulia De Falco, and Giuseppina Antonicelli, and Anna Onnis, and Stefano Lazzi, and Cristiana Bellan, and Lorenzo Leoncini
December 2011, Blood,
Copied contents to your clipboard!